Valensa teams with Neptune
This article was originally published in The Tan Sheet
Executive Summary
Valensa International extends its patented eye health formulas by adding Neptune Technologies and Bioressources' Neptune Krill Oil to its condition-specific dietary supplements. The Orlando, Fla., firm announced Oct. 6 it signed an exclusive, worldwide license with Neptune. It plans to launch the new eye and joint health formulas in the first quarter of 2010. Valensa is evaluating the efficacy of the new formulas in clinical trials now
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.